Photonic bone density spectroscopy market seen growing 8.2% annually through 2030

The photonic bone density spectroscopy device market is projected to rise from $1.26 billion in 2026 to $1.73 billion by 2030, driven by demand for non-invasive diagnostics and AI-enabled imaging. North America leads the market now, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Photonic bone density spectroscopy devices offer radiation-free bone assessment, which makes them relevant for earlier screening and long-term monitoring of osteoporosis and other bone disorders. - The market forecast signals growing adoption of non-invasive imaging tools across clinical and research settings.

What happened: - The Business Research Company projected the photonic bone density spectroscopy device market will reach $1.73 billion by 2030, up from $1.26 billion in 2026. - The forecast implies an 8.2% compound annual growth rate through 2030. - The market was estimated at $1.17 billion in 2025 and $1.26 billion in 2026, representing 8.0% growth in that one-year period. - The report was released July 21, 2026, from London. - The company published a sample request and a full report for the market study.

The details: - Photonic bone density spectroscopy devices use light-based technologies to measure bone density and bone quality without ionizing radiation. - The devices are designed to provide safe, painless and precise assessments. - The technology supports early diagnosis of osteoporosis and other bone conditions. - The market is being pushed by rising osteoporosis cases, broader demand for non-invasive imaging and stronger healthcare diagnostic infrastructure. - Growth drivers through 2030 include AI in diagnostic imaging, wider use of radiation-free imaging, portable and point-of-care devices, precision medicine, early disease detection, and cloud-enabled data sharing and analytics. - Expected product and platform innovations include AI-powered bone density analytics, non-ionizing laser-based multispectral bone assessment tools and cloud-connected imaging platforms for remote diagnostics. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is forecast to grow the fastest over the period.

Between the lines: - The forecast reflects a broader shift toward diagnostics that reduce radiation exposure and improve convenience for patients and providers. - The emphasis on portable devices and cloud connectivity suggests the market is moving beyond specialist imaging centers toward more distributed care settings. - The comparison to rising MRI referrals in the UK points to growing acceptance of non-invasive diagnostics more broadly, though that trend is not specific to bone imaging.

What's next: - The market’s next phase will likely center on AI integration, remote diagnostics and point-of-care deployment. - Asia-Pacific could become a key growth engine if adoption of non-invasive bone screening accelerates across the region. - The Business Research Company said its 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis. - The company said it offers more than 30,000 reports across 27 industries and 60 geographies, supported by 1,500,000 datasets and its Global Market Model platform.